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According to Greek mythology,
Scylla and Charybdis were two
fearsome monsters who
threatened Odysseus’s fleet of
ships as they passed through the
Strait of Messina. The names of
these legendary creatures have
now re-emerged as the identifiers
of two cell growth regulatory
genes in the fruit fly, Drosophila
melanogaster. Two recent reports
in Genes and Development
identify scylla and charybdis and
their mammalian orthologs,
REDD1 and REDD2, as key
players in the stress-response
network that coordinates cell
growth with the availability of
sufficient oxygen to support
anabolic metabolism [1,2].
Tuberous Sclerosis Complex
Acts Upstream of TOR Signaling
In metazoans, cell and tissue
growth is controlled by hormonal
factors and by the availability of
oxygen and nutrients. Studies in
flies and mammals have
highlighted the insulin/insulin-like
growth factor receptors (InRs) as
central components of the
hormonal network that controls
cell growth [3,4]. These receptors
transmit stimulatory signals for
protein synthesis and cell mass
accumulation, primarily through
the sequential activation of
phosphoinositide (PI) 3-kinase
and the protein kinase AKT (also
termed PKB). Until recently, the
mechanisms whereby nutrient and
oxygen supplies regulated cell
growth remained largely
mysterious. Compelling evidence
now suggests that these
bioenergetic precursors stimulate
anabolic metabolism, in part,
through the activation of TOR, an
evolutionarily conserved protein
serine/threonine kinase [4]. It now
appears that these metabolic
signals are relayed to TOR
through the heterodimeric
tuberous sclerosis complex (TSC)
[5]. Tuberous sclerosis is a human
autosomal dominant disorder
caused by loss of TSC function,
and is characterized by the
formation of benign tumors, called
hamartomas, in organs such as
the heart and brain. Interestingly,
hamartomatous lesions are also
common in several other
hereditary diseases in humans,
including Cowden’s disease and
Peutz–Jeghers Syndrome which
are caused by functional
inactivation of the lipid
phosphatase PTEN and of the
serine/threonine kinase LKB1,
respectively. The phenotypic
overlap among these three
genetic diseases is more than
coincidental, because PTEN,
LKB1 and TSC all serve as
upstream regulators of TOR
signaling [5–7].
The mechanism through which
TSC integrates into the TOR
signaling pathway and
downregulates cell growth has
recently been elucidated. TSC is
a heterodimeric complex
comprising TSC1 and TSC2, and
the TSC2 subunit is a GTPase-
activating protein (GAP) for the
Ras-related GTPase Rheb [5,8].
This small GTPase functions as a
positive growth effector
downstream of TSC, which
antagonizes Rheb function by
triggering the conversion of the
active GTP-bound form of this
protein to the inactive GDP-
bound state. When bound to
GTP, active Rheb collaborates
with TOR to mediate hallmark
events associated with TOR
signaling, including the
phosphorylation of the ribosomal
protein S6 kinase (S6K) and
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TOR Signaling: An Odyssey from
Cellular Stress to the Cell-Growth
Machinery
The target of rapamycin (TOR) protein kinase is centrally involved in
the coordination of cell growth and proliferation with the availability of
growth factors and nutrients. Two recent reports have illuminated a
mechanism whereby hypoxic stress dampens TOR signaling in
metazoan cells.
eukaryotic initiation factor (eIF)
4E-binding protein 1 (4E-BP1),
two key regulators of protein
synthesis. Exactly how Rheb
interacts with TOR remains a
major mystery — some evidence
suggests that Rheb acts
upstream of TOR, but the
possibility that Rheb and TOR
function in parallel pathways
cannot be excluded at this stage.
The mechanisms responsible
for regulation of TSC function by
growth factors and other external
stimuli are under intensive
investigation [5]. AKT
phosphorylates TSC2 and inhibits
the Rheb-GAP activity of TSC,
leading to the accumulation of
GTP-bound Rheb. Nutrients, such
as branched-chain amino acids,
also overcome the Rheb-
inhibitory function of TSC through
an ill-defined pathway.
Conversely, AMP-activated
kinase (AMPK) is stimulated to
phosphorylate TSC2 in ATP-
depleted cells, thereby increasing
the Rheb-GAP activity of TSC
[6,9,10]. It turns out that LKB1,
the gene mutated in
Peutz–Jeghers Syndrome,
encodes an upstream activating
protein kinase for AMPK [11,12].
These findings provided a
unifying molecular model to
explain the appearance of
hamartomas in PTEN-, LKB1- and
TSC-deficient humans — all three
types of mutation provoke
constitutive activation of the
Rheb–TOR pathway. Given that
these three molecules are also
bona fide tumor suppressors, we
can safely conclude that
constitutive activation of Rheb is
positively selected during
tumorigenesis.
A pathophysiological source of
energetic stress in both normal
and malignant tissues is hypoxia.
The heterodimeric transcription
factor, hypoxia-induced factor-1
(HIF-1) is activated at low oxygen
tensions, and orchestrates a
gene expression program that
generally promotes cellular
adaptation to hypoxic stress [13].
Hypoxia is also known to inhibit
the phosphorylation of S6K and
4E-BP1, suggesting that poorly
oxygenated cells suppress TOR-
dependent protein synthesis as
part of a global strategy to
conserve metabolic energy. An
earlier report indicated that acute
hypoxia inhibited S6K1 and 4E-
BP1 phosphorylation under
conditions that did not deplete
ATP sufficiently to trigger AMPK
activation [14]. Studies
performed by the Hafen and
Kaelin laboratories now provide
some provocative insights into
this AMPK-independent
mechanism of TOR suppression
in hypoxic cells [1,2].
Scylla and Charybdis as Negative
Regulators of TOR
Using Drosophila as a model
system, Reiling and Hafen [2]
identified novel suppressors of
the InR–TOR-linked growth
pathway with an elegant
enhancer–promoter-based
genetic screen. This screen was
intentionally biased to detect
genes that acted downstream of
phosphoinositide-dependent
protein kinase 1 (PDK1) and AKT
to suppress an eye overgrowth
phenotype. These studies
identified scylla as an effective
suppressor of this phenotype, due
largely if not entirely to a decrease
in average cell size. An in silico
search for scylla-related genes
yielded the highly homologous
charybdis, and subsequent
studies revealed that it too
suppressed the bulging eye
phenotype induced by
hyperactivation of AKT. The
authors also noted that a scylla
and charybdis homolog, REDD1,
was expressed in mammals. The
REDD1 gene had already been
identified as a transcriptional
target for HIF-1 in human cells,
and this mechanism of
transcriptional control appears to
be conserved in the fly [15,16].
Genetic studies in Drosophila
revealed that scylla acted
downstream of AKT and
upstream of TSC1/2, and, by
inference, placed scylla upstream
of Rheb/TOR as well. These
genetic data were confirmed in
biochemical experiments that
demonstrated a ∼50% reduction
in S6K activity in fly tissues from
scylla mutants. In Drosophila, the
PI 3-kinase–AKT–TOR signaling
axis promotes cell growth under
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Figure 1. Regulation of Rheb–TOR signaling by mitogenic and stress-inducing stimuli.
Growth factors stimulate Rheb–TOR signaling via inhibition of TSC, while both hypoxia
and nutrient depletion stimulate TSC-mediated Rheb-GAP activity thereby dampening
Rheb–TOR signaling. The newly defined Scylla/Redd1 pathway that impinges on TSC
and inhibits Rheb–TOR signaling is shown on the left. The related proteins Charyb-
dis/Redd2 (not shown) carry out functions that are partially redundant with those of
Scylla/Redd1. The figure highlights the three human tumor suppressors (PTEN, TSC
and LKB1, orange) that reside in pathways leading to inhibition of Rheb–TOR-depen-
dent cell growth. The interplay between GTP-bound Rheb and TOR (indicated by
broken arrows) may involve a physical interaction or may proceed through a parallel
pathway.
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nutrient-replete conditions;
however, under starvation
conditions, the pro-anabolic
effect of this pathway promotes a
negative energy balance, and, in
turn, decreased organismal
survival. Consistent with their
roles as downstream suppressors
of the PI 3-kinase pathway,
expression of scylla and
charybdis prolonged the lifespan
of starved flies.
REDD Proteins as Negative
Regulators of TOR
In parallel studies, Kaelin and
coworkers examined the role of
TSC in the regulation of TOR by
hypoxia in mammalian cells [1].
Experiments with Tsc2−/− mouse
embryo fibroblasts (MEFs) proved
that TSC function was required
for suppression of TOR signaling
by hypoxia. The Tsc2−/− MEFs
also displayed a marked
proliferative advantage relative to
their Tsc2+/+ counterparts when
cultured under 1% oxygen.
Consistent with the report by
Arsham et al. [14], the
LKB1–AMPK pathway was not
involved in the suppression of
TOR function by hypoxia. This
mechanism of TSC activation was
dependent on de novo gene
transcription and, in collaboration
with Reiling and Hafen, these
authors identified the REDD1
gene product as a candidate
regulator of TSC in hypoxic cells.
The REDD1 gene encodes a
widely expressed, low molecular
mass protein with no identifiable
functional domains [15,16]. A
second, related gene, REDD2,
may be a charybdis ortholog
because, like Charybdis, the
Redd2 protein exhibits a relatively
tissue-specific pattern of
expression [15,17]. Studies with
Redd1-overexpressing and
Redd1-deficient cells revealed
that Redd1 was required for
hypoxia-induced suppression of
TOR signaling, but was
dispensable for the negative
regulation of the TOR pathway
induced by nutrient deprivation, a
process that also depends on
TSC. The identification of scylla
and charybdis, and their putative
mammalian orthologs, REDD1 and
REDD2, adds further complexity
to our view of TOR regulation in
metazoan cells. Clearly, TSC
resides at the hub of multiple
pathways involved in the positive
or negative regulation of cell
growth and proliferation (Figure 1).
The scylla/REDD1 genes may
function as ‘rapid-response’
elements in an oxygen-sensitive
pathway that suppresses TOR
signaling during acute hypoxia. If
the hypoxic stress is protracted or
particularly intense, intracellular
ATP levels will eventually decline,
triggering AMPK activation, and,
in turn, an even stronger signal for
downregulation of Rheb–TOR
signaling.
Future Questions
These two new reports raise
several important questions. First,
understanding the mechanism
whereby Scylla/Redd1 influences
TSC function is of paramount
importance. Perhaps Scylla/Redd1
is a critical subunit of a protein
kinase that modifies TSC directly
or regulates Rheb function through
a parallel pathway. Second, given
that Redd1 is expressed in
response to multiple forms of
stress, other insults may relay
suppressive signals to TOR
through the Redd1–TSC axis.
Third, a complete understanding
of the interplay between Rheb and
TOR is an obligatory step toward
deciphering the roles of upstream
modulators, such as AKT, AMPK
and Scylla/Redd1, in the
regulation of signal transduction
through TOR. Finally, one wonders
whether Redd1 and/or Redd2 will,
like other members of this
fascinating signaling pathway, act
as tumor suppressors in humans.
Whatever the outcomes, this
chapter in the TOR odyssey sheds
new light on the integration of
stress response and mitogenic
signaling pathways in mammalian
cells.
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